Influence of cytokines onmdr1 expression in human colon carcinoma cell lines: Increased cytoxicity of MDR relevant drugs
- 1 August 1994
- journal article
- research article
- Published by Springer Nature in Zeitschrift für Krebsforschung und Klinische Onkologie
- Vol. 120 (8), 471-478
- https://doi.org/10.1007/bf01191800
Abstract
We investigated the effects of tumor necrosis factor (TNF) α, interferon (IFN) ψ and interleukin-2 (IL-2) on themdr1 gene expression in four human colon carcinoma cell lines (LoVo, HT 115, SW 480, and LS 174T) at different times (8. 24, 48, and 72h). We found no significant changes inmdr1 expression after 8h and 24h of cytokine treatment in all four lines. After 48h and 72h, however, a marked reduction ofmdr1 expression in LoVo, HT 115, and SW 480 cells and an unaffected expression in LS 174T cells was observed. We examined whether the cytokine-mediated reduction ofmdr1 expression correlates to the multidrug resistance (MDR) phenotype. In those cell lines showing a decreasedmdr1 expression after a long-term cytokine pretreatment we found a dramatic enhancement of cytotoxicity of the MDR relevant drugs vincristine and doxorubicin, whereas LS 174T cells remained resistant. By contrast, the simultaneous application of cytokines and cytostatics caused no additive or synergistic effects. We conclude that in certain colon carcinoma cell lines a decreasedmdr1 expression caused by prolonged cytokine pretreatment correlates with an enhanced cytotoxicity of drugs susceptible to MDR as an MDR-overcoming effect.This publication has 40 references indexed in Scilit:
- Tumor necrosis factor activities and cancer therapy — A perspectivePharmacology & Therapeutics, 1993
- Overcoming Multidrug Resistance in Human Tumor Cells Using Free and Liposomally Encapsulated Antisense OligodeoxynucleotidesBiochemical and Biophysical Research Communications, 1993
- Staurosporine reduces P-glycoprotein expression and modulates multidrug resistanceCancer Letters, 1993
- Confluence‐dependent resistance in human colon cancer cells: Role of reduced drug accumulation and low intrinsic chemosensitivity of resting cellsInternational Journal of Cancer, 1992
- Modulation of Activity of the Promoter of the Human MDR 1 Gene by Ras and p53Science, 1992
- Dexamethasone prevents the growth inhibitory effects of recombinant tumor necrosis factor in a rat hepatoma cell line reuber-RC-3: An association with the changes in the messenger RNA levels for multidrug resistance geneBiochemical and Biophysical Research Communications, 1991
- P‐glycoprotein expression and schedule dependence of adriamycin cytotoxicity in human colon carcinoma cell linesInternational Journal of Cancer, 1991
- Chemosensitivity Patterns and Expression of Human Multidrug Resistance-Associated MDR1 Gene by Human Gastric and Colorectal Carcinoma Cell LinesJNCI Journal of the National Cancer Institute, 1990
- Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cellsCell, 1986
- A NEW MARKER FOR HUMAN CANCER CELLS. 1. THE Ca ANTIGEN AND THE Cal ANTIBODYThe Lancet, 1982